AstraEye Labs
Sign InEnter the Lab
AstraEye Labs · Research methods · FELIX
FELIXU.S. equitiesSpace Analyst plan

Cross-Analysis Synthesis

Compare this run's other completed equity analyses for the same ticker and call out where they agree or disagree

  1. 01
    What it answers
  2. →
    Read a real report
Impersonal research. AstraEye Labs is not a registered investment adviser, does not give financial advice, and does not know your goals or risk tolerance. This research does not account for your individual goals, risk tolerance, financial situation, or other circumstances. Past performance does not predict future results.
01The analysis

What it answers

Reads back FELIX's own already-completed equity analyses for the same ticker earlier in this run (health check, valuation, margins, balance-sheet risk, and others) and, only where 2 or more exist for a ticker, identifies confluence (multiple analyses pointing the same way) or contradiction (e.g. valuation screening expensive while guidance revisions are improving) between them. Every figure it cites is verified against the metrics those analyses already computed before publishing - it never computes a new number itself. A ticker with only one completed analysis this run, or whose comparison can't be verified, produces no synthesis rather than a placeholder.

Scientist
FELIX
Asset class
U.S. equities
Securities it can describe
Stocks, ETFs and mutual funds
Plan
Included from the Space Analyst plan
02The method

No written method here

A written method for this analysis is not published on this page.

✦Read a real report

From a method to a finding

Published reports are readable without an account. The newest is Ether (ETH) and XRP extend a month-long slide as Bitcoin falls below $75,000: trend, momentum and news (Nov 9, 2026). Create an account to run research on the stocks and crypto you choose.